序号 |
标题 |
次数 |
作者 |
发布时间 |
86896 |
苯乙炔基聚硅氧烷(PE-PDMS) |
146 |
WYQ |
2024-11-22 |
86897 |
DOTA-NAPamide trifluoroacetate;935886-72-9 |
89 |
wyh |
2024-11-22 |
86898 |
二乙炔基苯(PDEB)PDEB具有一个苯环和两个乙炔基团 |
223 |
WYQ |
2024-11-22 |
86899 |
CAS:173308-19-5 DOTA Tris-(t-butyl ester) Ethylenediamino Monoamide |
94 |
zyl |
2024-11-22 |
86900 |
DOTA-RGD,DOTA-cRGDfK |
97 |
kx |
2024-11-22 |
86901 |
Octreotide;奥曲肽 |
114 |
wyh |
2024-11-22 |
86902 |
DOTA-NHS-酯 六氟磷酸盐 TFA 盐 DOTA-NHS-ester Hexafluorophosphate TFA Salt |
104 |
zyl |
2024-11-22 |
86903 |
DOTA-NHS-酯 六氟磷酸盐 TFA 盐 DOTA-NHS-ester Hexafluorophosphate TFA Salt |
156 |
zyl |
2024-11-22 |
86904 |
Ga-DOTA-TOC acetate ;293295-70-2 |
103 |
wyh |
2024-11-22 |
86905 |
聚(间二乙炔基苯-苯基氢硅烷)(PDBS) |
152 |
WYQ |
2024-11-22 |
86906 |
端乙炔基材料4,4′-双(3-乙炔基苯氧基)二苯基砜(ATS) |
84 |
WYQ |
2024-11-22 |
86907 |
DOTA-mono-NHS tris (t-Bu ester) Hydrogen Hexafluorophosphate |
99 |
wyh |
2024-11-22 |
86908 |
CAS:127985-74-4 p-SCN-Bn-DOTA |
101 |
zyl |
2024-11-22 |
86909 |
聚甲基硅次乙炔基硅烷(MSE) |
129 |
WYQ |
2024-11-22 |
86910 |
聚苯基二乙炔基苯硅烷(MSP) |
171 |
WYQ |
2024-11-22 |
86911 |
N,N-二炔丙基-3-乙炔基苯胺(DPEA) |
130 |
WYQ |
2024-11-22 |
86912 |
乙炔基封端的氢化超支化聚碳硅烷(EHBP) |
95 |
WYQ |
2024-11-22 |
86913 |
CAS:819869-77-7 DOTA-tris(tBu)ester NHS ester |
87 |
zyl |
2024-11-22 |
86914 |
CAS:180978-54-5 DOTA-Biotin-Sarcosine DOTA-生物素-肌氨酸 |
92 |
zyl |
2024-11-22 |
86915 |
端乙炔基聚醚酰亚胺改性硅芳炔树脂(PEI-PSA) |
110 |
WYQ |
2024-11-22 |
86916 |
DOTA 偶联肽,NOTA-E(cRGDfK)2,NOTA标记多肽氨基酸试剂 |
145 |
kx |
2024-11-22 |
86917 |
Lutetium (177Lu) oxodotreotide;437608-50-9 |
108 |
wyh |
2024-11-22 |
86918 |
CAS:2125661-62-1 Butyne-DOTA |
98 |
zyl |
2024-11-22 |
86919 |
端乙炔基聚醚酰亚胺(PEI)(Polyetherimide,简称PEI) |
224 |
WYQ |
2024-11-22 |
86920 |
碳/聚硅乙炔基防热复合材料(C/PMR) |
140 |
WYQ |
2024-11-22 |
86921 |
聚(间二乙炔基苯-甲基氢硅烷)树脂(PSA) |
270 |
WYQ |
2024-11-22 |
86922 |
P-氨基苯乙炔基共轭侧基的聚对苯撑乙炔(PAnPE) |
121 |
WYQ |
2024-11-22 |
86923 |
DOTA-G5 DOTA修饰修饰第5代(G5)聚(酰胺基胺)树枝状聚合物 |
128 |
zcy |
2024-11-22 |
86924 |
DOTA-PEG5-azide 大环化合物-五聚乙二醇-叠氮 |
93 |
zyl |
2024-11-22 |
86925 |
1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid, a-(2-carboxyethyl)-, 1,4,7,10-tetrakis(1,1-dimethylethyl) ester |
113 |
wyh |
2024-11-22 |
86926 |
DOTA功能化的聚赖氨酸 |
131 |
zcy |
2024-11-22 |
86927 |
聚乳酸-羟基乙酸共聚物-大环配体 |
130 |
wyh |
2024-11-22 |
86928 |
DOTA-Tyr3-thre8-奥曲肽 DOTA-Tyr3-Thre8-octreotide |
106 |
zcy |
2024-11-22 |
86929 |
1,4,7,10-Tetrakis(aminocarbonylmethyl)-1,4,7,10-tetraazacyclododecane |
93 |
wyh |
2024-11-22 |
86930 |
BKT140CXCR4 antagonist-DOTA |
107 |
zyl |
2024-11-22 |
86931 |
CAS:181065-46-3 p-NH2-Bn-DOTA(B-200) |
111 |
zyl |
2024-11-22 |
86932 |
DOTA di(tBu)ester;913542-71-9 |
125 |
wyh |
2024-11-22 |
86933 |
10,10'-[(5-硝基-1,3-苯基)双(亚甲基)]双[1,4,7,10-四氮杂环十二烷-1,4,7-三乙酸],三氟乙酸盐;1175002-77-3 |
97 |
wyh |
2024-11-22 |
86934 |
(R)-tert-Bu4-DOTAGA;817562-90-6 |
112 |
wyh |
2024-11-22 |
86935 |
DOTA-Bevacizumab DOTA-贝伐单抗 |
114 |
zcy |
2024-11-22 |
86936 |
10-[2-[(3,5-二羧基苯基)氨基]-2-氧乙基]-1,4,7,10-四氮杂环十二烷-1,4,7-三乙酸,三氟乙酸盐 |
104 |
wyh |
2024-11-22 |
86937 |
DOTA接枝N-乙烯基吡咯烷酮-丙烯醛P(VP-Ac)共聚物 DOTA-VP-Ac |
117 |
zcy |
2024-11-22 |
86938 |
DOTA-HYNIC-IPSMA |
112 |
wyh |
2024-11-22 |
86939 |
PEG-GO 聚乙二醇化超小GO氧化石墨烯的二维纳米材料 |
271 |
zcy |
2024-11-22 |
86940 |
CAS1227407-76-2 叠氮基-单-酰胺-DOTA Azido-mono-amide-DOTA |
95 |
zyl |
2024-11-22 |